Please wait
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fiarman Jeffrey

(Last) (First) (Middle)
3400 PLAYERS CLUB PARKWAY

(Street)
MEMPHIS TN 38125

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Frontdoor, Inc. [ FTDR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, CLO & Secretary
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/07/2025 M 15,762 A $34.48 50,408(1) D
Common Stock 08/07/2025 M 18,299 A $35.56 68,707 D
Common Stock 08/07/2025 M 23,488 A $24.74 92,195 D
Common Stock 08/07/2025 M 72,124 A $26.42 164,319 D
Common Stock 08/07/2025 S 129,673 D $56.1456(2) 34,646 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (Right to Buy) $34.48 08/07/2025 M 15,762 (3) 03/29/2029 Common Stock 15,762 $0 0 D
Employee Stock Options (Right to Buy) $35.56 08/07/2025 M 18,299 (4) 03/30/2030 Common Stock 18,299 $0 0 D
Employee Stock Options (Right to Buy) $24.74 08/07/2025 M 23,488 (5) 06/01/2032 Common Stock 23,488 $0 0 D
Employee Stock Options (Right to Buy) $26.42 08/07/2025 M 72,124 (6) 03/27/2033 Common Stock 72,124 $0 0 D
Explanation of Responses:
1. Includes 284 aggregate shares of the Company's common stock acquired under the Frontdoor, Inc. 2019 Employee Stock Purchase Plan on June 30, 2025.
2. This transaction was executed in multiple trades at prices ranging from $55.94 to 57.04, inclusive. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
3. Non-qualified stock options granted on March 29, 2019 vested 25% on March 29, 2020, and thereafter vested 6.25% quarterly over the next three years on the quarterly anniversary of the grant date, such that all shares vested on March 29, 2023, subject to continued employment with the Company.
4. Non-qualified stock options granted on March 30, 2020 vested 25% on March 30, 2021, and thereafter vested 6.25% quarterly over the next three years on the quarterly anniversary of the grant date, such that all shares vested on March 30, 2024, subject to continued employment with the Company.
5. Reflects non-qualified stock options with time- and performance-based vesting conditions awarded to the Reporting Person on June 1, 2022. The performance criteria vested in three performance tranches, each with a separate performance condition based on the volume-weighted average price of the Company's common stock on the NASDAQ of $35.00, $40.00 and $45.00, respectively, over any 20 consecutive trading-day period. The service condition was satisfied on June 1, 2023. The performance-vesting criteria was met on August 18, 2023, August 9, 2024 and September 23, 2024 for the first, second and third tranches of the award, respectively, as certified by the Compensation Committee of the Company's Board of Directors.
6. Reflects non-qualified stock options with time- and performance-based vesting conditions awarded to the Reporting Person on March 27, 2023. The performance criteria vested in three performance tranches, each with a separate performance condition based on the volume-weighted average price of the Company's common stock on the NASDAQ of $32.23, $35.14 and $38.31, respectively, over any 20 consecutive trading-day period. The service condition was satisfied on March 27, 2024. The performance-vesting criteria was met on July 20, 2023, August 8, 2023 and August 2, 2024 for the first, second and third tranches of the award, respectively, as certified by the Compensation Committee of the Company's Board of Directors.
Stephanie Delavale, as Attorney-In-Fact for Jeffrey Fiarman 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.